DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Asthma	R-HSA-444620	map05310	procainamide	4913	drug-path
Regulation of actin cytoskeleton	R-HSA-392751	map04810	procainamide	4913	drug-path
Gap junction	R-HSA-190861	map04540	procainamide	4913	drug-path
Allograft rejection	R-HSA-9679028	map05330	procainamide	4913	drug-path
Type I diabetes mellitus	R-HSA-5683209	map04940	procainamide	4913	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	procainamide	4913	drug-path
Apoptosis	R-HSA-109581	map04210	procainamide	4913	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	procainamide	4913	drug-path
Parkinson's disease	R-HSA-1643685	0	procainamide	4913	drug-path
Ribosome	R-HSA-5368277	map03010	procainamide	4913	drug-path
Calcium signaling pathway	R-HSA-381753	map04020	procainamide	4913	drug-path
Olfactory transduction	R-HSA-9751605	map04740	ethionamide	2761171	drug-path
Acute myeloid leukemia	R-HSA-9680350	map05221	ethionamide	2761171	drug-path
MAPK signaling pathway	R-HSA-9652817	map04010	ethionamide	2761171	drug-path
Phosphatidylinositol signaling system	R-HSA-1280215	map04070	nafcillin	6093	drug-path
Olfactory transduction	R-HSA-9751605	map04740	nafcillin	6093	drug-path
Systemic lupus erythematosus	R-HSA-977105	map05322	nafcillin	6093	drug-path
Apoptosis	R-HSA-109581	map04210	nafcillin	6093	drug-path
Gap junction	R-HSA-190861	map04540	liothyronine	5920	drug-path
Neuroactive ligand-receptor interaction	R-HSA-5632681	map04080	liothyronine	5920	drug-path